ACC introduces screening program for early detection of Oral Cancer
The program emphasizes public awareness, routine screening, and targeted intervention particularly for high-risk individuals, including tobacco users, alcohol consumers, those with HPV-16 infection, and people with prior oral lesions.
As part of this initiative, ACC has partnered with the Isha Foundation to provide holistic support for individuals seeking to overcome tobacco addiction.
This collaboration integrates physical health interventions with mental and emotional wellness support.
'Tobacco users are six to seven times more likely to develop oral cancer than non-users.Oral cancer is one of the few cancers that can be detected early through a simple oral examination. With this program, our goal is to detect cases early—before it's too late.' said Dr. Umanath Nayak Senior Consultant Head and Neck Oncology Surgeon at Apollo Cancer Centre.
Oral cancer is the most common cancer among Indian men and is rising steadily among women. Incidence rates vary widely across states: West Bengal reports the highest, while Kerala sees the lowest.
Maharashtra, Ahmedabad Urban, and Meghalaya also report alarmingly high figures—largely driven by tobacco use.
Chennai-based studies have identified an increase in cancers of the tongue base and floor of the mouth, sites known for high metastatic potential.
The buccal mucosa remains the most frequently affected site nationwide.
Notably, smokeless tobacco use is rising among women, contributing to a narrowing gender gap in incidence rates.
Risk factors—such as the combined use of smokeless tobacco, betel quid, and alcohol—are especially prevalent in underserved communities with limited access to preventive care. The disease is increasingly affecting individuals aged 31–50, with poor nutrition further exacerbating the risk.
'Our objective is to foster a culture of preventive healthcare. Oral cancer is highly treatable when detected early. We urge everyone over 30, especially tobacco users to undergo screening.' said Dr. Arsheed Hakeem Consultant - Head & Neck Surgical Oncology, Apollo Cancer Centre, Jubilees Hills, Hyderabd.
The #OraLife, the Oral Cancer Screening Program, involves a comprehensive visual and tactile oral examination conducted by trained medical oncologists and head & neck surgeons.
It aims to identify early warning signs such as persistent ulcers, red or white patches, lumps, and non-healing sores—many of which are often overlooked.
Apollo has teamed up with the Isha Foundation to incorporate spiritual well-being into its tobacco cessation efforts. As part of this, individuals will have access to a simple, yet effective 7-minute guided meditation led by Sadhguru.
'Miracle of Mind' is a free meditation app that empowers individuals to take charge of their well-being.
' Our collaboration with Isha Foundation is a testament to our belief in integrated care, where early detection and mental wellness are both critical pillars.' Dr. Abhishek Budharapu, - Head & Neck Surgical Oncology, Apollo Cancer Centre said.
Research indicates that tobacco users spend over Rs 1.1 lakh more on healthcare over their lifetime compared to non-users. The consequences extend beyond health—tobacco use reduces life expectancy, raises insurance premiums, limits claim payouts, and destabilizes families, particularly when primary earners are affected.
UNI KNR BD
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
3 minutes ago
- The Hindu
Simpler tests could slash biosimilar costs, widen patient access
Most of the drugs that we consume are called 'small molecule drugs'. Their chemical structure is reasonably simple. Disprin, for instance, has a molecular weight of around 180 daltons. There is another breed of drugs that are very large, complex molecules. For instance, the molecular weight of insulin is around 5,800 daltons and that of the monoclonal antibody remicade, about 150,000 daltons. (One dalton is equal to one-12th the mass of a carbon-12 atom.) Small molecule drugs also tend to have fixed structures that do not change for the duration of their use. In contrast, the complex molecules, which we call biologics, are produced in biological systems and therefore during their production slight variations in the structure may arise. However, these variations may have no impact on the stability of the molecule, its efficacy or its side effects. When a company produces a small molecule drug for the first time, it seeks patent protection for that drug. That is, no competitor may make that drug for several years. It is only when the drug goes 'off patent' that competitors may make it. In the absence of competition, the originator company can price the drug very high. Once there is competition, the competitor companies produce generics, which are copies of the original drug. They don't undertake the research and development to make the drug and they may not spend as much on marketing and sales, so the costs of generics are also much lower. Most of the drugs that you and I take are generics and are priced very cheaply compared to the originator drug. A good example is Sovaldi, a drug used to treat hepatitis C: it originally cost $84,000 for a 12-week course in the US but that dropped to $1,000 once Indian generic firms started making it. Largely it is generic drugs that keep us in India alive and well. Since biologics made by a generic firm will be produced by different biological systems, they may not be identical to those made by the originator company. Thus they are called biosimilars, not generics. For many years, a debate has raged over how much proof is required for a manufacturer to prove that a given biosimilar will work as well as the original biologic drug. Therefore, whereas much simpler testing was required to show that a generic small molecule was working like the originator molecule, there are more elaborate and expensive tests for biosimilars. Major drug regulators such as those of the US, the UK, and in Europe have been working to determine how they can simplify the requirements for approving a biosimilar, in view of the availability of modern analytical techniques. For example, the UK has removed animal trials and the US has planned to replace them with more human-relevant methods (like using organoids). In India, this requirement has not yet been updated although there is a proposal to waive animal studies on a case-by-case basis. Some have also argued that India should follow the practices of the UK and the US. The same holds for the more expensive clinical trials, which in the UK are currently required only in certain cases. Biosimilars need to be made less expensively while ensuring efficacy and minimal adverse effects. The larger the number of affordable biosimilars, the more options we will have for our patients. Gayatri Saberwal is a consultant at the Tata Institute for Genetics and Society.
Time of India
2 hours ago
- Time of India
GMCH, AIIMS-N Set Benchmarks In Organ Donation & Transplant, Win National Awards
Nagpur: The city has emerged as a national beacon in the field of organ donation and transplantation, with the Government Medical College & Hospital (GMCH), Nagpur, and AIIMS-Nagpur receiving prestigious awards at the 15th Indian Organ Donation Day (IODD) organized in New Delhi on Saturday. GMCH was conferred the 'Best Brain Stem Death Certifying Team' award while AIIMS-Nagpur bagged the 'Emerging Govt Institution in Organ Donation and Transplantation' award. The awards, presented by Union health minister JP Nadda at the event organised by the National Organ and Tissue Transplant Organisation (NOTTO) under the Ministry of Health & Family Welfare, mark a significant milestone in Vidarbha's growing leadership in public healthcare and transplant services. On behalf of GMCH, medical superintendent Dr Avinash Gawande received the award that recognizes exemplary work in facilitating organ donation through accurate and ethical certification procedures. Over the past year, GMCH facilitated 11 cadaveric organ donations, resulting in the retrieval of 21 kidneys, 10 livers, and 18 corneas. The hospital has so far performed 90 kidney transplants, including India's first robotic kidney transplant in a govt hospital conducted on July 20, 2025. AIIMS-Nagpur was honoured for its rapid and impactful entry into the organ transplantation space. Since initiating its transplant programme in December 2022, AIIMS-Nagpur recorded 22 deceased organ donations, including 18 brain stem deaths (BSD) and 4 Donation after Circulatory Death (DCD) cases. Notably, AIIMS-Nagpur became the first AIIMS in the country and only the third medical institution in India to successfully perform a DCD-based organ transplant, setting a precedent for other govt institutions. Speaking on the national recognition for GMCH, Dr Gawande said, "This reflects the commitment of our entire team to provide ethical, advanced, and life-saving care through organ transplantation." Dr PP Joshi, executive director of AIIMS-Nagpur, stressed that this is just the beginning. "AIIMS-Nagpur is committed to making a long-term impact in this field. We aim to create a model that blends clinical excellence with compassion and public awareness," he said. GMCH dean Dr Raj Gajbhiye announced that the Superspeciality Hospital (SSH) is ready to handle all kinds of organ transplants. "The heart transplant is expected to begin within two months. We are technically and medically ready for kidney and liver transplants, and heart transplant capability is on the immediate horizon," he said. # MAJOR PUSH FOR ORGAN DONATION — GMCH-Nagpur Award: Best Brain Stem Death Certifying Team Brain Stem Death Donations (last 1 year): 11 Organs Retrieved: Kidneys 21; Livers 10; Corneas 18 Total Kidney Transplants Performed: 90 — AIIMS-Nagpur Award: Emerging Govt Institution in Organ Donation and Transplantation Total Kidney Transplants: 46: Live Donor: 14; Deceased Donor: 32 Total Deceased Donors: 22 Bone Marrow Transplants: 11 Get the latest lifestyle updates on Times of India, along with Friendship Day wishes , messages and quotes !
Time of India
2 hours ago
- Time of India
HC seeks fresh report on condition of SCB's central kitchen
1 2 Cuttack: Orissa high court has asked the advocates' committee of the High Court Bar Association to revisit the central kitchen of SCB Medical College and Hospital, Cuttack and submit a fresh report, following allegations of preparation of food under unhygienic conditions for patients. The court was hearing the matter based on a report submitted by the committee on Thursday. The report, based on an inspection on June 30, highlighted serious health concerns, including non-functional roti-making machines and unsanitary conditions posing risk to patient health. The court was shown video footage that revealed lapses like kitchen staff collecting rotis without gloves, many without head and mouth covers, and personnel wearing shoes being allowed inside the kitchen area. Taking on record an affidavit filed by the SCB superintendent, the division bench comprising Justices S K Sahoo and V Narasingh asked the committee to submit a fresh report. The matter is scheduled for further hearing on Sept 11. In his affidavit filed on July 29, SCB superintendent Dr Goutam Kumar Satapathy stated that the hospital has 2,772 functional beds. However, a surplus number of patients are being admitted and accommodated beside the beds and are being provided with medical services and food. Indoor patients are being provided with cooked and dry diet thrice a day as per the requirement received from different wards and departments. Satapathy acknowledged the issues raised in the report and stated that food services had been outsourced to a Berhampur-based agency in line with National Health Mission (NHM) guidelines. The agency has been given space, power, and water to operate on the hospital premises. He informed the court that mechanical roti preparation had resumed on July 21 using new machines with conveyor belt roasting. Civil and electrical renovation work in the kitchen, undertaken by the roads and buildings department, is expected to be completed by the end of Aug. Rodent control measures will follow. A meeting of the hospital's diet vigilance committee was held on July 4, where steps to improve kitchen hygiene and efficiency were discussed. The hospital superintendent assured the court that strict hygiene protocols would be enforced. Get the latest lifestyle updates on Times of India, along with Friendship Day wishes , messages and quotes !
